(Q46555031)

English

Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis

scientific article published on 5 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

0 references

Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Pantelis A Sarafidis

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

Panagiotis C Stafylas

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

Aggeliki I Kanaki

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

Anastasios N Lasaridis

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

publication date

5 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

21

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

922-929

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

Excerpts from the United States Renal Data System 2006 Annual Data Report.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Antihypertensive therapy in the presence of proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

ACE-inhibitor use and the long-term risk of renal failure in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Renoprotective effects of renin-angiotensin-system inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

21 January 2018

Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotection by blocking the RAAS in diabetic nephropathy—fact or fiction?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.206

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/AJH.2008.206

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18535536

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46555031&oldid=2118089277"